↓ Skip to main content

Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer

Overview of attention for article published in Cochrane database of systematic reviews, August 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter
7 tweeters
facebook
3 Facebook pages
wikipedia
1 Wikipedia page

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
113 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer
Published in
Cochrane database of systematic reviews, August 2013
DOI 10.1002/14651858.cd009256.pub2
Pubmed ID
Authors

Tiago B de Castria, Edina MK da Silva, Aecio FT Gois, Rachel Riera

Abstract

An estimated 220,000 new cases of non-small cell lung cancer (NSCLC) and 160,000 deaths are expected to occur in the US in 2013, representing about 28% of cancer-related mortality. Approximately 75% of these people will have locally advanced or metastatic disease and will be treated in a palliative setting. Platinum-based combination chemotherapy has benefits in terms of survival and symptom control when compared with best supportive care.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 113 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Malaysia 1 <1%
Japan 1 <1%
United States 1 <1%
Colombia 1 <1%
Unknown 109 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 19%
Student > Ph. D. Student 18 16%
Researcher 17 15%
Student > Bachelor 11 10%
Other 11 10%
Other 33 29%
Unknown 1 <1%
Readers by discipline Count As %
Medicine and Dentistry 60 53%
Unspecified 15 13%
Nursing and Health Professions 9 8%
Pharmacology, Toxicology and Pharmaceutical Science 6 5%
Biochemistry, Genetics and Molecular Biology 5 4%
Other 17 15%
Unknown 1 <1%

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 January 2018.
All research outputs
#1,893,268
of 12,527,219 outputs
Outputs from Cochrane database of systematic reviews
#4,233
of 8,923 outputs
Outputs of similar age
#24,803
of 154,586 outputs
Outputs of similar age from Cochrane database of systematic reviews
#50
of 115 outputs
Altmetric has tracked 12,527,219 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 154,586 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 115 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.